Evidence map›Paper›PMID 32578710›Full record

ArticleRevista da Sociedade Brasileira de Medicina Tropical2020

Mucocutaneous leishmaniasis in a cocaine user: diagnostic and therapeutic knowledge.

Lissiê Lunardi Sbroglio, Viviane Maria Maiolini, Irene Machado Moraes Alvarenga Rabelo, Gabriela Almeida Giraldelli, Luciana Patrícia Tuccori, Rodrigo Guimarães Cunha

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Revista da Sociedade Brasileira de Medicina Tropical, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lissiê Lunardi SbroglioUniversidade do Estado do Rio de Janeiro, Programa de Residência Médica em Dermatologia, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-0888-9065
Viviane Maria MaioliniUniversidade do Estado do Rio de Janeiro, Programa de Residência Médica em Dermatologia, Rio de Janeiro, RJ, Brasil.
Irene Machado Moraes Alvarenga RabeloUniversidade do Estado do Rio de Janeiro, Programa de Residência Médica em Dermatologia, Rio de Janeiro, RJ, Brasil.
Gabriela Almeida GiraldelliUniversidade do Estado do Rio de Janeiro, Programa de Pós-Graduação em Dermatologia, Rio de Janeiro, RJ, Brasil.
Luciana Patrícia TuccoriUniversidade do Estado do Rio de Janeiro, Programa de Residência Médica em Infectologia, Rio de Janeiro, RJ, Brasil.
Rodrigo Guimarães CunhaUniversidade do Estado do Rio de Janeiro, Departamento de Infectologia, Rio de Janeiro, RJ, Brasil.
Universidade do Estado do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucocutaneous leishmaniasis (MCL) is a chronic infection that can affect the skin and mucous membranes. We report a case of oral, nasopharyngeal, and penile lesions in a 35-year-old cocaine user. The patient presented with ulcerated lesions in 2014. Histopathologic analysis revealed amastigotes, and serological test results were positive for leishmaniasis. Systemic therapy with meglumine antimoniate was administered; however, the patient failed to present for follow-up. In 2018, he returned with nasal collapse, and another histopathologic test confirmed MCL. This case illustrates the importance of careful differential diagnosis of skin and mucous ulcers to identify the particular pathology.

Indexed as

AdultAntiprotozoal AgentsCocaine-Related DisordersHumansLeishmaniasis, MucocutaneousMaleMeglumine AntimoniateAntiprotozoal AgentsMeglumine Antimoniate

Identifiers

PMID32578710
PMCPMC7310364
OpenAlexW3037692602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.